Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

17.58
+0.58003.41%
Post-market: 17.600.0200+0.11%19:30 EDT
Volume:1.95M
Turnover:34.35M
Market Cap:3.42B
PE:-35.11
High:17.85
Open:17.38
Low:17.30
Close:17.00
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:91.34M
Volume Ratio:0.60
T/O Rate:2.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:2.78
PE(LYR):-10.85

Loading ...

Analysts Are Bullish on These Healthcare Stocks: AnaptysBio (ANAB), Legend Biotech (LEGN)

TIPRANKS
·
May 13

Barclays Reaffirms Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
May 13

Legend Biotech Corp : TD Cowen Raises Target Price to $29 From $21

THOMSON REUTERS
·
May 13

GENSCRIPT BIO Surges Over 5% as Associate Legend Biotech Reports Narrowed Loss and Strong CARVYKTI® Sales Growth

Stock News
·
May 13

Legend Biotech (LEGN) Valuation Check After Strong Revenue Growth And Narrowing Quarterly Loss

Simply Wall St.
·
May 13

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Tvardi Therapeutics (TVRD) and Organigram Global (OGI)

TIPRANKS
·
May 13

Legend Biotech Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Legend Biotech reports Q1 EPS (3c), consensus (17c)

TIPRANKS
·
May 12

Genscript flags Legend Biotech Q1 results and cautions investors on risk

TIPRANKS
·
May 12

Legend Biotech Q1 2026 Results Show CARVYKTI-Fueled Revenue Surge and Narrowing Losses

TIPRANKS
·
May 12

Legend Biotech Q1 revenue slightly misses estimates

Reuters
·
May 12

Legend Biotech Q1 FY26 net loss narrows 46.24% to $54.3 million; revenue rises to $305.1 million

Reuters
·
May 12

Legend Biotech Q1 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $305.100M Miss $307.035M Estimate

Benzinga Earnings
·
May 12

Legend Biotech Corp - Reports Cash and Cash Equivalents, Time Deposits of $834.6 Mln as of March 31, 2026

THOMSON REUTERS
·
May 12

Legend Biotech Corporation Q1 Pretax Profit USD -53.1 Million

THOMSON REUTERS
·
May 12

Legend Biotech Corporation Q1 Adjusted EPS USD -0.03 VS. Ibes Estimate USD -0.02

THOMSON REUTERS
·
May 12

Legend Biotech Reports First Quarter 2026 Results and Recent Highlights

GlobeNewswire
·
May 12

Legend Biotech's Q1 2026 Earnings Preview: CARVYKTI Sales Projected at Approximately $597 Million

Deep News
·
May 11

Earning Preview: Legend Biotech Q1 revenue is expected to increase by 58.58%, and institutional views are bullish

Earnings Agent
·
May 05

Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth

GlobeNewswire
·
May 04